Propanc Biopharma is progressing preparations for its Phase 1b First-In-Human clinical trial of PRP, an investigational proenzyme therapy for advanced cancer patients with solid tumors. Key activities include finalizing clinical protocols, site feasibility, vendor selection, and regulatory submissions, aiming for ethics approval in November 2026 and first patient screening by February 2027. PRP targets cancer stem cells to prevent recurrence and metastasis, with prior human data supporting safety. This trial marks a critical step toward clinical evaluation and potential new treatment options for metastatic cancer patients.
Propanc Biopharma's clinical development preparation for its PRP Phase 1b study is noted here as context. For readers following the health sector, Pluang's market snapshot as of Oct 28, 2026 19:11 WIB shows that out of 150 priced US health stocks, 42 rose and 97 fell. Notable movers include GEHC at USD 77.00 (+8.28%), BNGO at USD 1.12 (-8.20%) with a typical hold time of 51 days, and ACB at USD 4.44 (+6.99%).
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
